EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 64 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $20,000 | -33.3% | 39,500 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $30,000 | +11.1% | 39,500 | +49.1% | 0.01% | 0.0% |
| Q1 2020 | $27,000 | -34.1% | 26,500 | 0.0% | 0.01% | -14.3% |
| Q4 2019 | $41,000 | -14.6% | 26,500 | 0.0% | 0.01% | -12.5% |
| Q3 2019 | $48,000 | +11.6% | 26,500 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $43,000 | -8.5% | 26,500 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $47,000 | -13.0% | 26,500 | -7.0% | 0.01% | -20.0% |
| Q4 2018 | $54,000 | -47.1% | 28,500 | 0.0% | 0.01% | -37.5% |
| Q3 2018 | $102,000 | +72.9% | 28,500 | 0.0% | 0.02% | +60.0% |
| Q2 2018 | $59,000 | – | 28,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 41,909,219 | $21,793,000 | 11.58% |
| Kore Private Wealth LLC | 202,366 | $105,000 | 0.02% |
| BARD ASSOCIATES INC | 335,750 | $175,000 | 0.02% |
| HighTower Advisors, LLC | 5,284,688 | $2,738,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 126,529 | $66,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 654,200 | $339,000 | 0.01% |
| Virtu Financial LLC | 57,076 | $30,000 | 0.01% |
| WEDBUSH SECURITIES INC | 81,500 | $42,000 | 0.00% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 33,933 | $18,000 | 0.00% |
| MATRIX ASSET ADVISORS INC/NY | 39,500 | $20,000 | 0.00% |